China Nuclear Engineering Co (601611.SS) stock: key figures, P/E, revenue and dividend
Industrials · Construction & Engineering · China · ISIN CNE100002896
China Nuclear Engineering Co financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 113.54 bn CNY | 101.92 bn CNY |
| Gross profit | 13.29 bn CNY | 12.38 bn CNY |
| Operating income | 3.26 bn CNY | 6.74 bn CNY |
| EBIT | 5.17 bn CNY | 5.33 bn CNY |
| Net income | 2.06 bn CNY | 1.32 bn CNY |
| Diluted EPS – continuing operations | 0.57 CNY | 0.44 CNY |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About China Nuclear Engineering Co
China Nuclear Engineering Corporation Limited engages in the nuclear power, industrial, and civil engineering businesses in China and internationally. It is involved in the construction of nuclear power plants, high temperature reactors, heavy water reactors, fast reactors, water reactors, and other types of reactor, as well as industrial and civil engineering construction services. The company was founded in 2010 and is headquartered in Shanghai, China. China Nuclear Engineering Corporation Limited operates as a subsidiary of China National Nuclear Corporation.
More stocks
- INTERNATIONAL BANCSHARES CORP (IBOC)
- Hangcha Group Co Ltd (603298.SS)
- Eastern Air Logistics Co Ltd (601156.SS)
- Changchun High & New Technology Industries Group Inc (000661.SZ)
- KILROY REALTY CORP (KRC)
- Tangshan Port Group Co Ltd (601000.SS)
- Grupo Simec S.A.B. de C.V (SIMECB.MX)
- Red Avenue New Materials Group Co Ltd (603650.SS)
- VALVOLINE INC (VVV)
- Indivior Pharmaceuticals, Inc. (INDV)
- FIRST BANCORP /PR/ (FBP)
- Volvo Car AB (VOLCAR B.ST)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.